Study Title: Phase I/II Study of Ixazomib and Romidepsin in Relapsed/ Refractory Peripheral T-cell Lymphoma (PTCL): Big Ten Cancer Research Consortium BTCRC-HEM15-028
 

• Status: Terminated

• Participating sites:
  • University of Illinois Cancer Center
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center
  • Holden Comprehensive Cancer Center, University of Iowa
  • University of Michigan Rogel Cancer Center
  • Masonic Cancer Center, University of Minnesota
  • Rutgers Cancer Institute of New Jersey
  • Barbara Ann Karmanos Cancer Center
• Learn more:
  • clinicaltrials.gov: NCT03547700
  • Big Ten CRC News Release

Study Contact: studies@hoosiercancer.org; (317) 921-2050.